Cepharanthine Inhibits Enterovirus Entry by Endolysosomal Deacidification and Exhibits Protective Activity In Vivo
October 2025
in “
Antimicrobial Agents and Chemotherapy
”
Studysummary This study found that cepharanthine may be a promising treatment for enterovirus infections, as it offered full protection to mice against lethal EV71 challenges and reduced viral titers and pathology.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on journals.asm.org →